Cabaletta Bio: Sector Headwinds And Funding Issues... But Also Some Clear Clinical Direction
Source: SeekingAlpha
2025-06-11 09:49:25 ET
Topline Summary and Update
Read the full article on Seeking Alpha
For further details see:
Cabaletta Bio: Sector Headwinds And Funding Issues... But Also Some Clear Clinical Direction
Cabaletta Bio Inc.
NASDAQ: CABA
CABA Trading
3.82% G/L:
$3.1713 Last:
934,997 Volume:
$3.07 Open:
CABA Latest News
March 23, 2026 07:30:00 am
Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
February 24, 2026 08:00:00 am
Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference
CABA Stock Data
$250,770,856
85,435,369
1.33%
21
N/A
Biotechnology & Life Sciences
Healthcare
US
Philadelphia
